Studies of the serum therapy of type E botulism. 3.
D000284:Administration, Oral; D000818:Animals; D000992:Antitoxins / Q000097:blood / Q000627:therapeutic use*; D001906:Botulism / Q000209:etiology / Q000628:therapy*; D003014:Clostridium botulinum; D000882:Haplorhini; D007275:Injections, Intravenous; D051379:Mice; D011817:Rabbits; D013997:Time Factors; D014118:Toxins, Biological / Q000097:blood / Q000633:toxicity
D000992:Antitoxins; D014118:Toxins, Biological